Regeneron Pharmaceuticals, Inc.
386.6700
1.30%
386.6700
1.30%
340.0900 543.5518
52 weeks
52 weeks

Mkt Cap 40.36B

Shares Out 104.38M

new Chat
Send me real-time posts from this site at my email

Regeneron Pharmaceuticals's President Regeneron Laboratori just picked up 43,348 shares

George Yancopoulos, Regeneron Pharmaceuticals's President Regeneron Laboratori and a director of the company, recently acquired 43,348 shares of the company. The buys took place at prices ranging from $11.64 to $580.29 per share, on dates ranging from October 30 to November 02, 2015. Yancopoulos now owns 1,118,590 shares of the company. Yancopoulos operates out of Tarrytown, NY. Some additional info was provided as follows:

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 1,200 shares of Company stock on November 2, 2015 at prices ranging from $561.26 to $561.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will p rovide full information regarding the number of shares sold by the reporting person on November 2, 2015 at each separate price. Represents volume-weighted average price of sales of 530 shares of Company stock on November 2, 2015 at prices ranging from $563.07 to $563.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2015 at each separate price. Represents volume-weighted average price of sales of 1,000 shares of Company stock on November 2, 2015 at prices ranging from $564.00 to $564.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2015 at each separate price. Represents volume-weighted average price of sales of 1,000 shares of Company stock on November 2, 2015 at prices ranging from $565.78 to $565.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2015 at each separate price. Represents volume-weighted average price of sales of 1,700 shares of Company stock on November 2, 2015 at prices ranging from $566.17 to $566.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2015 at each separate price. Represents volume-weighted average price of sales of 1,350 shares of Company stock on November 2, 2015 at...

More
Cancel
Followers
10